The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate Cancer

NCT00295750 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

620

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Degarelix
DRUG: Degarelix
DRUG: Leuprolide 7.5 mg

Sponsor

Ferring Pharmaceuticals